首页> 外文期刊>Life sciences >Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.
【24h】

Chronic losartan treatment decreases angiotensin II-mediated facilitation of noradrenaline release in the caudal artery of spontaneously hypertensive rats.

机译:慢性氯沙坦治疗可降低自发性高血压大鼠尾动脉中血管紧张素II介导的去甲肾上腺素释放的促进作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Sympathetic activity is modulated by angiotensin II (AII), both at pre- and postsynaptic level in the rat caudal artery. In the spontaneously hypertensive rat (SHR), this artery receives more dense sympathetic innervation than blood vessels of normotensive strains. This fact seems to be linked to the enhanced pressor responses elicited by noradrenaline in SHR. In this work we describe, in the SHR, the effect of a chronic treatment with the angiotensin II AT1-receptor antagonist, losartan, in modulating noradrenergic mechanisms involved in caudal artery contraction. The effect of losartan is compared to that of captopril, given at doses leading to a similar decrease of both arterial blood pressure and left ventricular hypertrophy. The contractile response of caudal artery rings induced by endogenous noradrenaline released by low frequency transmural nerve stimulation (TNS) has been studied. Under our conditions, TNS (0.5-1 Hz) induced higher contractile responses in SHR treated with losartan than in the control and captopril-treated groups. This difference seems to be due to an increase of the postsynaptic effect of noradrenaline (NA) rather than to an increase of noradrenaline release from sympathetic endings, since i) DE50 value for NA was lower in losartan-treated SHR than in the other groups, and ii) AII induced a dose-dependent increase of TNS-evoked release of radioactivity from caudal artery segments loaded with [3H]-NA, in both control and captopril-treated groups but had no effect in the losartan-treated group. These results show that chronic treatment with losartan, although slightly enhancing the pressor effect of NA at postsynaptic level, fully supresses the facilitatory role of AII on NA release.
机译:在鼠尾动脉的突触前和突触后水平,血管紧张素II(AII)调节交感神经活动。在自发性高血压大鼠(SHR)中,该动脉比正常血压菌株的血管接受更密集的交感神经支配。这一事实似乎与去甲肾上腺素在SHR中引起的升压反应增强有关。在这项工作中,我们在SHR中描述了用血管紧张素II AT1受体拮抗剂洛沙坦进行的慢性治疗在调节涉及尾动脉收缩的去甲肾上腺素能机制中的作用。将氯沙坦的作用与卡托普利的作用进行比较,其剂量可导致动脉血压和左心室肥大的相似降低。研究了低频经壁神经刺激(TNS)释放的内源性去甲肾上腺素引起的尾动脉环的收缩反应。在我们的条件下,洛沙坦治疗的SHR中TNS(0.5-1 Hz)引起的收缩反应比对照组和卡托普利治疗的组更高。这种差异似乎是由于去甲肾上腺素(NA)的突触后作用增加,而不是由于交感神经末梢去甲肾上腺素的释放增加,因为i)氯沙坦治疗的SHR中NA的DE50值低于其他组, ii)在对照组和卡托普利治疗组中,AII均引起剂量依赖性增加TNS诱发的负载[3H] -NA的尾动脉节段放射性的释放,但在氯沙坦治疗组中无作用。这些结果表明,氯沙坦的慢性治疗虽然在突触后水平上略微增强了NA的加压作用,但完全抑制了AII对NA释放的促进作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号